Taysha stock surges on positive trial design and FDA alignment
-- Shares of Taysha Gene Therapies (NASDAQ:TSHA) soared 19% today after the company announced pivotal trial design...
-- Shares of Taysha Gene Therapies (NASDAQ:TSHA) soared 19% today after the company announced pivotal trial design...
Curaçao, Curaçao, May 29th, 2025, Chainwire Bet20 Casino (EPA:CASP), owned and operated by Platinum Technology...
-- Shares of Veeva Systems (NYSE:VEEV) surged 15% following the company’s announcement of better-than-expected first...
(Reuters) - JPMorgan has named HSBC’s former global head of mergers and acquisitions, Kamal Jabre, as its new M&A Vice Chair to...
-- Pharmaceutical companies, Daichii Sankyo and Merck (NSE:PROR), on Thursday made the decision to pull back their...
-- Fast-fashion retailer Shein announced on Thursday that it plans to significantly increase its product safety and...
-- JetBlue Airways (NASDAQ:JBLU) and United Airlines announced on Thursday a consumer collaboration plan, "Blue...
-- Keros Therapeutics announced on Thursday the discontinuation of all development of its drug, cibotercept, for...
By David Shepardson (Reuters) -JetBlue Airways and United Airlines unveiled on Thursday plans for a consumer collaboration that...
-- Nvidia (NASDAQ:NVDA) is facing new accusations from U.S. lawmakers over its close ties with China, according to a...